Stockholders' Equity - Schedule of Warrant Activity (Details) - Warrant [Member] - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Class of Warrant or Right [Line Items] | |||
| Warrants,Warrants outstanding | 47,093 | 64,966 | 15,096 |
| Weighted Average Exercise Price Per Share,Warrants outstanding | $ 1.56 | $ 7.99 | $ 4.84 |
| Total Weighted Average Remaining Contractual Life,Warrants outstanding | 2 years 8 months 12 days | 1 year 6 months 3 days | 6 years 7 days |
| Warrants,Warrants exercisable | 64,966 | ||
| Weighted Average Exercise Price Per Share,Warrants exercisable | $ 7.99 | ||
| Total Weighted Average Remaining Contractual Life,Warrants exercisable | 1 year 6 months 3 days | ||
| Warrants,Granted | 64,669 | ||
| Weighted Average Exercise Price Per Share,Granted | $ 8.01 | ||
| Total Weighted Average Remaining Contractual Life,Granted | 1 year 7 months 13 days | ||
| Warrants,Forfeited/Expired | (14,799) | (31,997) | |
| Weighted Average Exercise Price Per Share,Forfeited/Expired | $ 4.84 | $ 0.01 | |
| X | ||||||||||
- Definition The number of shares warrants exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price per share, warrants exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual life, granted. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|